snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Team Member Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)


0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to email@email.com
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    email@email.com

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    B2G/B2B/B2C, Cells technology Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology (1)

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (3)

    Product Stage 

    Employees 

    Location 

    Status 
    Processing your search... This may take a moment
    162 Startups 11 In the News 15 Recently Updated
    • Total Funding
      $2.6B
      Raised
      252
      Events
    • Private Funding
      $1.14B
      Raised
      161
      Rounds
    • Public Offerings
      $1.32B
      Raised
      76
      Offerings
    • M&A
      $142.9M
      Raised
      15
      Deals
    2015
    2025
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    Nectin Therapeutics logo

    Nectin Therapeutics

    Next-generation Immunotherapy Agents
    2017 B2B 11-50 A $36M
    biotechnology
    pharmaceuticals
    oncology
    immunology
    cancer-therapy
    cancer
    antibodies
    patients
    drug-delivery
    treatments
    +8
    NeoTX logo

    NeoTX

    Immuno-oncology Drug Development
    2015 B2B 11-50 C $63M
    drug-development
    drug-discovery
    biopharmaceutical
    cancer-therapy
    oncology
    cancer
    therapeutics
    immunotherapy
    cell-therapy
    pharmaceuticals
    +8
    Neurogenesis logo

    Neurogenesis

    Neurodegenerative Disease Cell Therapy
    2018 B2B 1-10 A $6.66M
    pharmaceuticals
    cell-therapy
    amyotrophic-lateral-sclerosis-(als)
    +1
    Neuromagen Pharma logo

    Neuromagen Pharma

    Novel Drugs for Neurodegenerative Diseases
    2021 B2B 1-10 Seed $2.5M
    pharmaceuticals
    amyotrophic-lateral-sclerosis-(als)
    degenerative-diseases
    drug-development
    cells
    +2
    NeuroMed logo

    NeuroMed

    PRESUMED INACTIVE
    Treatment for Neurological Degenerative Diseases
    2005 B2B 1-10 Acquired $1M
    therapeutics
    cell-therapy
    degenerative-diseases
    neurology
    pharmaceuticals
    +3
    New Phase logo

    New Phase

    Therapeutic Hyperthermia Technology
    2013 B2B 11-50 A $35M
    therapeutics
    nanotechnology
    cells
    medical-devices
    biotechnology
    cell-therapy
    cancer-therapy
    +5
    NewStem logo

    NewStem

    PRESUMED INACTIVE
    Precision Medicine Therapeutics
    2016 B2B 1-10 Seed $5M
    clinics
    data-analytics
    hospitals
    healthcare-providers
    cancer-therapy
    diagnostics
    personalized-medicine
    chemotherapy
    oncology
    genetic-disorders
    +8
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    162 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $2.6B
      Raised
      252
      Events
    • Private Funding
      $1.14B
      Raised
      161
      Rounds
    • Public Offerings
      $1.32B
      Raised
      76
      Offerings
    • M&A
      $142.9M
      Raised
      15
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    Nectin Therapeutics logo
    Raised
    $36M
    Nectin Therapeutics
    Next-generation Immunotherapy Agents
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    NeoTX logo
    Raised
    $63M
    NeoTX
    Immuno-oncology Drug Development
    Founded:2015
    Business Model:B2B
    Employees:11-50
    Funding Stage:C
    Neurogenesis logo
    Raised
    $6.66M
    Neurogenesis
    Neurodegenerative Disease Cell Therapy
    Founded:2018
    Business Model:B2B
    Employees:1-10
    Funding Stage:A
    Neuromagen Pharma logo
    Raised
    $2.5M
    Neuromagen Pharma
    Novel Drugs for Neurodegenerative Diseases
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    NeuroMed logo
    Raised
    $1M
    NeuroMed
    PRESUMED INACTIVE
    Treatment for Neurological Degenerative Diseases
    Founded:2005
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    New Phase logo
    Raised
    $35M
    New Phase
    Therapeutic Hyperthermia Technology
    Founded:2013
    Business Model:B2B
    Employees:11-50
    Funding Stage:A
    NewStem logo
    Raised
    $5M
    NewStem
    PRESUMED INACTIVE
    Precision Medicine Therapeutics
    Founded:2016
    Business Model:B2B
    Employees:1-10
    Funding Stage:Seed
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,